EDUCATE STUDY (EDUCATING CLINICIANS TO ACHIEVE TREATMENT GUIDELINE EFFECTIVENESS): DEVELOPMENT AND IMPLEMENTATION

2.50
Hdl Handle:
http://hdl.handle.net/10755/164706
Category:
Abstract
Type:
Presentation
Title:
EDUCATE STUDY (EDUCATING CLINICIANS TO ACHIEVE TREATMENT GUIDELINE EFFECTIVENESS): DEVELOPMENT AND IMPLEMENTATION
Author(s):
Friedman, Lyssa; Engelking, Constance; Harvey, Catherine; Wickham, Rita; Miller, Kimberly L.
Author Details:
Lyssa Friedman, RN BSN MPA, Director, Clinical Research, McKesson Specialty Oncology Services, San Rafael, California, USA, email: lfriedman@noainc.com; Constance Engelking, RN, MS, OCN, The CHE Group, Mt. Kisco, New York; Catherine D. Harvey, DrPH, RN, AOCN, The Oncology Group, Raleigh, North Carolina; Rita Wickham, PhD, RN, AOCN, CHPN, Rush University, Chicago, Illinois; Kimberly L. Miller, PhD, Ovation Research Group, San Francisco, California
Abstract:
Febrile neutropenia is a dose-limiting toxicity of chemotherapy; fatigue due to chemotherapy-induced anemia is also common. These side effects can lead to life-threatening infections, increase costs, and may reduce patientsÆ quality of life. National Oncology Alliance (NOA) offers peer-reviewed anemia and neutropenia guidelines consistent with nationally-recognized guidelines yet customized to office-based oncology practice. Research shows that distribution of treatment guidelines alone is insufficient to change knowledge or clinical practice. An educational program targeted to health care providers (HCPs) to improve guideline adherence may improve adherence and lead to improved patient outcomes. The EDUCATE study (EDUcating Clinicians to Achieve Treatment guideline Effectiveness) is designed to evaluate whether an educational intervention program targeted to HCPs on adherence to anemia and neutropenia treatment guidelines improves guideline adherence in the community-based setting. The 12-month educational program, based on NOAÆs anemia and neutropenia guidelines, is tailored to the office-based setting, where nurses have collaborative roles and can facilitate guideline adherence. Community- based oncology practices in five US regions were randomized to the intervention (education) or control (no education) group (2:1 ratio). A total of 1568 practices were approached for participation, 122 practices responded, 49 practices were ineligible and 26 practices declined participation. The unit of analysis in the study is the HCP; 82 HCPs in 47 randomized community-based practices were enrolled. The same educational program was offered to all clinicians in the intervention sites (registered nurses, physicians, nurse practitioners, physician assistants, pharmacists, licensed practical nurses). The educational program employs several learning formats to reinforce risk assessment for neutropenia and anemia, appropriate growth factor use and dosing and patient monitoring. The educational program introduces a new topic monthly and varies the presentation weekly to include one of the following: email case vignette with quiz, educational mailer with peer-reviewed article, educational giveaway, patient education resource and/or study newsletter. Oncology nurse educators play a key role in education delivery, providing three educational in-service trainings and implementing customized standing orders for neutropenia risk assessment, anemia assessment and appropriate growth factor use. Comparison of education versus no education on guideline adherence and patient outcomes will be reported at study completion.
Repository Posting Date:
27-Oct-2011
Date of Publication:
27-Oct-2011
Conference Date:
2007
Conference Name:
32nd Annual Oncology Nursing Society Congress
Conference Host:
Oncology Nursing Society
Conference Location:
Las Vegas, Nevada, USA
Note:
This is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.

Full metadata record

DC FieldValue Language
dc.type.categoryAbstracten_US
dc.typePresentationen_GB
dc.titleEDUCATE STUDY (EDUCATING CLINICIANS TO ACHIEVE TREATMENT GUIDELINE EFFECTIVENESS): DEVELOPMENT AND IMPLEMENTATIONen_GB
dc.contributor.authorFriedman, Lyssaen_US
dc.contributor.authorEngelking, Constanceen_US
dc.contributor.authorHarvey, Catherineen_US
dc.contributor.authorWickham, Ritaen_US
dc.contributor.authorMiller, Kimberly L.en_US
dc.author.detailsLyssa Friedman, RN BSN MPA, Director, Clinical Research, McKesson Specialty Oncology Services, San Rafael, California, USA, email: lfriedman@noainc.com; Constance Engelking, RN, MS, OCN, The CHE Group, Mt. Kisco, New York; Catherine D. Harvey, DrPH, RN, AOCN, The Oncology Group, Raleigh, North Carolina; Rita Wickham, PhD, RN, AOCN, CHPN, Rush University, Chicago, Illinois; Kimberly L. Miller, PhD, Ovation Research Group, San Francisco, Californiaen_US
dc.identifier.urihttp://hdl.handle.net/10755/164706-
dc.description.abstractFebrile neutropenia is a dose-limiting toxicity of chemotherapy; fatigue due to chemotherapy-induced anemia is also common. These side effects can lead to life-threatening infections, increase costs, and may reduce patientsÆ quality of life. National Oncology Alliance (NOA) offers peer-reviewed anemia and neutropenia guidelines consistent with nationally-recognized guidelines yet customized to office-based oncology practice. Research shows that distribution of treatment guidelines alone is insufficient to change knowledge or clinical practice. An educational program targeted to health care providers (HCPs) to improve guideline adherence may improve adherence and lead to improved patient outcomes. The EDUCATE study (EDUcating Clinicians to Achieve Treatment guideline Effectiveness) is designed to evaluate whether an educational intervention program targeted to HCPs on adherence to anemia and neutropenia treatment guidelines improves guideline adherence in the community-based setting. The 12-month educational program, based on NOAÆs anemia and neutropenia guidelines, is tailored to the office-based setting, where nurses have collaborative roles and can facilitate guideline adherence. Community- based oncology practices in five US regions were randomized to the intervention (education) or control (no education) group (2:1 ratio). A total of 1568 practices were approached for participation, 122 practices responded, 49 practices were ineligible and 26 practices declined participation. The unit of analysis in the study is the HCP; 82 HCPs in 47 randomized community-based practices were enrolled. The same educational program was offered to all clinicians in the intervention sites (registered nurses, physicians, nurse practitioners, physician assistants, pharmacists, licensed practical nurses). The educational program employs several learning formats to reinforce risk assessment for neutropenia and anemia, appropriate growth factor use and dosing and patient monitoring. The educational program introduces a new topic monthly and varies the presentation weekly to include one of the following: email case vignette with quiz, educational mailer with peer-reviewed article, educational giveaway, patient education resource and/or study newsletter. Oncology nurse educators play a key role in education delivery, providing three educational in-service trainings and implementing customized standing orders for neutropenia risk assessment, anemia assessment and appropriate growth factor use. Comparison of education versus no education on guideline adherence and patient outcomes will be reported at study completion.en_GB
dc.date.available2011-10-27T12:05:30Z-
dc.date.issued2011-10-27en_GB
dc.date.accessioned2011-10-27T12:05:30Z-
dc.conference.date2007en_US
dc.conference.name32nd Annual Oncology Nursing Society Congressen_US
dc.conference.hostOncology Nursing Societyen_US
dc.conference.locationLas Vegas, Nevada, USAen_US
dc.description.noteThis is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.-
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.